Yao Zizhen, Jaeger Jochen C, Ruzzo Walter L, Morale Cecile Z, Emond Mary, Francke Uta, Milewicz Dianna M, Schwartz Stephen M, Mulvihill Eileen R
Department of Pathology, University of Washington, Seattle, Washington 98195, USA.
BMC Genomics. 2007 Sep 12;8:319. doi: 10.1186/1471-2164-8-319.
Marfan syndrome (MFS) is a heritable connective tissue disorder caused by mutations in the fibrillin-1 gene. This syndrome constitutes a significant identifiable subtype of aortic aneurysmal disease, accounting for over 5% of ascending and thoracic aortic aneurysms.
We used spotted membrane DNA macroarrays to identify genes whose altered expression levels may contribute to the phenotype of the disease. Our analysis of 4132 genes identified a subset with significant expression differences between skin fibroblast cultures from unaffected controls versus cultures from affected individuals with known fibrillin-1 mutations. Subsequently, 10 genes were chosen for validation by quantitative RT-PCR.
Differential expression of many of the validated genes was associated with MFS samples when an additional group of unaffected and MFS affected subjects were analyzed (p-value < 3 x 10-6 under the null hypothesis that expression levels in cultured fibroblasts are unaffected by MFS status). An unexpected observation was the range of individual gene expression. In unaffected control subjects, expression ranges exceeding 10 fold were seen in many of the genes selected for qRT-PCR validation. The variation in expression in the MFS affected subjects was even greater.
马凡综合征(MFS)是一种由原纤维蛋白-1基因(fibrillin-1)突变引起的遗传性结缔组织疾病。该综合征是主动脉瘤疾病中一个重要的可识别亚型,占升主动脉和胸主动脉瘤的5%以上。
我们使用斑点膜DNA宏阵列来识别那些表达水平改变可能导致该疾病表型的基因。我们对4132个基因进行分析,确定了一个子集,该子集在来自未受影响对照的皮肤成纤维细胞培养物与来自已知原纤维蛋白-1突变的受影响个体的培养物之间存在显著的表达差异。随后,选择了10个基因通过定量RT-PCR进行验证。
当对另一组未受影响和受MFS影响的受试者进行分析时,许多经验证基因的差异表达与MFS样本相关(在培养的成纤维细胞中的表达水平不受MFS状态影响的零假设下,p值<3×10-6)。一个意外的观察结果是单个基因表达的范围。在未受影响的对照受试者中,许多选择用于qRT-PCR验证的基因的表达范围超过10倍。在受MFS影响的受试者中,表达的变化甚至更大。